Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA
- PMID: 9439439
Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA
Abstract
Processed pseudogenes of residual contaminating genomic DNA interfere with a sensitive detection of cytokeratin 18 (CK18) mRNA by reverse transcription and polymerase chain reaction (RT-PCR). This may cause false-positive results when CK18 mRNA is used as a marker for ectopic tumor cells in specimens from cancer patients. To establish a sensitive CK18 RT-PCR by excluding the amplification of processed pseudogenes, the following strategy was chosen: (a) CK18 pseudogene sequences were cloned from genomic DNA by PCR; (b) cDNA-specific primers were designed on the basis of mismatches between pseudogenes and cDNA; (c) PCR conditions were adjusted to reach maximum sensitivity and specificity. Epithelial cells (1-10) could be detected in 1 mL of blood. Among the numerous CK18 genes homologous to the transcribed gene, at least two different processed pseudogenes exist that are highly homologous to each other and to the exons of the transcribed CK18 gene.
Similar articles
-
Diagnosis of micrometastases by the amplification of tissue-specific genes.Gene. 1995 Jun 14;159(1):43-7. doi: 10.1016/0378-1119(94)00522-t. Gene. 1995. PMID: 7541767
-
mRNA-specific reverse transcription-polymerase chain reaction from human tissue extracts.Anal Biochem. 2002 Aug 15;307(2):304-15. doi: 10.1016/s0003-2697(02)00058-1. Anal Biochem. 2002. PMID: 12202248
-
Exclusive amplification of cDNA template (EXACT) RT-PCR to avoid amplifying contaminating genomic pseudogenes.Biotechniques. 2001 Oct;31(4):776-8, 780, 782. doi: 10.2144/01314st03. Biotechniques. 2001. PMID: 11680707
-
The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods.Ann Oncol. 1998 Dec;9(12):1269-76. doi: 10.1023/a:1008445604263. Ann Oncol. 1998. PMID: 9932154 Review.
-
Tumour diagnosis by PCR-based detection of tumour cells.Scand J Clin Lab Invest Suppl. 1995;221:116-21. doi: 10.3109/00365519509090575. Scand J Clin Lab Invest Suppl. 1995. PMID: 7652485 Review.
Cited by
-
Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells.Med Oncol. 2001;18(1):33-8. doi: 10.1385/MO:18:1:33. Med Oncol. 2001. PMID: 11778968
-
Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes.Br J Cancer. 1999 Nov;81(5):870-3. doi: 10.1038/sj.bjc.6690778. Br J Cancer. 1999. PMID: 10555760 Free PMC article.
-
Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro.Br J Cancer. 1998 Nov;78(9):1194-8. doi: 10.1038/bjc.1998.653. Br J Cancer. 1998. PMID: 9820179 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources